Based on PubMed | Can a skin rash occur in advanced endometrial cancer, and what are the likely causes, warning signs, and when should it prompt urgent medical evaluation?

Skin rashes can occur in people with advanced endometrial (uterine) cancer, but the reasons vary widely from common treatment side effects to rare cancer-related skin conditions and some patterns require urgent medical attention. Most rashes are related to therapy (chemotherapy or immunotherapy) and are manageable, but rashes with blistering, peeling, pain, or systemic symptoms deserve prompt evaluation. ^{[1] [2]}

Common Causes of Rash in Advanced Endometrial Cancer

• Cancer treatments (most common)

  • Chemotherapy combinations such as carboplatin + paclitaxel can cause red, bumpy, dry, and itchy rashes; sometimes skin can peel or blister, especially in areas previously exposed to radiation (radiation recall). Moisturizing and avoiding irritants may help, but any worsening rash should be reported. ^{[1] [3]}
  • Immunotherapy (e.g., PD‑1/PD‑L1 inhibitors combined with chemotherapy) can cause immune-related skin toxicity rashes, pruritus (itching), blistering, ulceration, and even skin necrosis in severe cases. Radiation recall with vesicles, peeling, or ulcers can also occur at prior radiation sites. ^[2]
  • General immunotherapy skin care guidance advises calling the care team if skin is peeling or blistering, if there are new nodules, or if a rash is accompanied by fever or other systemic symptoms. Topical steroids and sun-protection are often recommended under clinician guidance. ^{[4] [5]}

• Photosensitivity and radiation recall

  • Some chemotherapy regimens can make skin unusually sensitive to sun, leading to rash that looks like sunburn, with redness, swelling, and blistering; this can happen weeks to months after treatment and warrants clinician input. Sun protection and avoiding extremes of temperature are recommended. ^{[6] [7] [8]}

• Infections and allergic reactions

  • Treatment-related immunosuppression can predispose to bacterial, viral, or fungal skin infections that may present with redness, warmth, pain, or pus. Allergic drug eruptions may also occur and can range from mild hives to serious blistering reactions. ^[4]
  • Drug references for immune agents and other therapies advise seeking immediate help for rash with fever, blistering/peeling, mouth sores, facial swelling, or breathing problems, as these may signal severe hypersensitivity or systemic inflammation. These are emergencies. ^{[9] [10] [11] [12]}

• Less common cancer-related causes

  • Paraneoplastic dermatoses are rare skin conditions triggered by internal cancers; in endometrial cancer, reported examples include acanthosis nigricans (velvety darkened skin), “tripe palms” (thick, velvety palms), and acquired hypertrichosis lanuginosa (sudden fine hair growth). Their sudden appearance can foreshadow cancer progression or recurrence and should prompt medical evaluation. ^{[13] [14] [15]}
  • Cutaneous metastases from endometrial cancer are uncommon but possible; they usually present as firm, sometimes tender nodules or plaques rather than a flat rash and often indicate widespread disease. Recognition matters because it can change staging and treatment planning. ^{[16] [17]}

---

What a Rash Might Look Like by Cause

• Chemo- or immunotherapy-related rash: Red, bumpy, itchy patches; can become dry, peel, or blister; may flare in previously irradiated areas (radiation recall). Usually starts days to weeks after treatment cycles. ^{[1] [3] [2]}
• Photosensitivity: Sun-exposed areas become red, swollen, or blistered, resembling severe sunburn. Prevention with sun protection is key. ^[6]
• Allergic or severe immune reaction: Rapidly spreading rash, hives, painful mouth sores, fever, facial swelling, eye redness, or breathing problems. This pattern needs urgent care. ^{[9] [11]}
• Infection: Localized redness, warmth, pain, swelling, pus, or fever. Immunosuppression can make skin infections more likely and more serious. ^[4]
• Paraneoplastic dermatoses: New velvety dark plaques in body folds (acanthosis nigricans), thickened velvety palms (tripe palms), or sudden fine hair growth on face/body (hypertrichosis lanuginosa). Their onset may parallel cancer activity. ^{[13] [14] [15]}
• Cutaneous metastases: New firm, often fixed skin or subcutaneous nodules or plaques that may grow over time; sometimes painful or ulcerated. Suggests dissemination and needs biopsy. ^{[16] [17]}

---

Red Flags That Warrant Urgent Medical Attention

Seek same-day or emergency care for any of the following patterns, as they can signal severe drug toxicity, infection, or other urgent problems:

• Blistering or peeling skin; painful or rapidly spreading rash; ulcers or areas of skin death (necrosis). ^{[2] [4]}
• Rash with fever, mouth sores, swollen eyes, facial swelling, trouble breathing, chest tightness, or hoarseness. ^{[9] [11]}
• Rash at prior radiation sites with vesicles, peeling, or ulceration (“radiation recall”), especially if worsening. ^{[2] [3]}
• New lumps, nodules, or plaques in the skin especially if firm or growing because these can represent skin metastases and should be biopsied. ^{[4] [16]}
• Signs of infection (redness with heat, pain, pus, rapidly expanding redness) or systemic illness (chills, severe fatigue). ^[4]

---

When to Contact Your Oncology Team

• Call promptly for any new or worsening rash during or after chemotherapy or immunotherapy, even if mild, to get early guidance on skincare, medication adjustments, or need for examination. Early management often prevents escalation. ^{[1] [2]}
• Report rash focused in prior radiation fields because radiation recall can emerge weeks to months after therapy and is treatable when caught early. ^[3]
• Tell your team about new unusual skin findings such as suddenly thicker, darker skin in folds, velvety palms, or new fine hair growth, as these may be paraneoplastic clues and merit broader cancer assessment. ^{[13] [14] [15]}
• Alert your team to new firm skin nodules or plaques, which may represent metastasis and require imaging and biopsy. ^{[16] [17]}

---

Practical Self-Care Tips (While You Await Guidance)

• Use gentle, fragrance-free moisturizers regularly to reduce dryness and itching; avoid scratching and harsh soaps. Avoid tight clothing and protect skin from sun with SPF 30–50+, long sleeves, and hats. ^{[1] [6]}
• If you recently had immunotherapy and develop a rash, avoid direct sun and call your care team early; topical steroid creams may be prescribed if appropriate. ^{[5] [4]}
• If you received prior radiation, watch that area closely for delayed redness, blisters, or peeling, and notify your team if changes appear. ^{[3] [2]}

---

Prognosis and Why It Matters

• Most therapy-related rashes are manageable with supportive care and medication adjustments; they do not necessarily indicate treatment failure. ^{[1] [4]}
• Paraneoplastic rashes or cutaneous metastases are uncommon, but when present, they can signal cancer activity or spread and may impact staging and treatment decisions; timely recognition can optimize care plans. Skin examination is a valuable part of follow-up in endometrial cancer. ^{[16] [13] [17]}

---

Quick Reference Table: Rash Types, Clues, and Actions

Rash type	Typical clues	What to do	Why it matters
Chemo/immunotherapy rash	Red, bumpy, itchy; dry; may peel or blister; can localize to prior radiation fields	Call oncology team; use gentle moisturizers; may need topical steroids or treatment hold per clinician	Common and treatable; severe cases can escalate without early care [1] [2] [3]
Photosensitivity	Sun-exposed redness/swelling/blisters; “bad sunburn” look	Strict sun protection; notify team if severe	Preventable; some regimens heighten sun sensitivity [6]
Severe immune/drug reaction	Blistering/peeling, mouth sores, fever, facial/eye swelling, breathing issues	Urgent/emergency care	May indicate serious hypersensitivity or immune toxicity [9] [11] [4]
Infection	Redness, warmth, pain, pus; +/- fever	Urgent assessment, possible antibiotics	Immunosuppression raises risk and severity [4]
Paraneoplastic dermatoses	Sudden acanthosis nigricans, tripe palms, hypertrichosis lanuginosa	Report promptly; may prompt restaging	Can foreshadow progression or recurrence [13] [14] [15]
Cutaneous metastases	New firm nodules/plaques, growing; sometimes tender/ulcerated	Prompt dermatology/oncology exam and biopsy	Indicates possible dissemination; changes staging/therapy [16] [17]

---

Bottom line

A skin rash can certainly occur in advanced endometrial cancer, most often from chemotherapy or immunotherapy, and it is usually manageable with early guidance; however, rashes with blistering/peeling, pain, fever, breathing problems, or new firm skin nodules should prompt urgent medical evaluation. ^{[1] [2] [4] [16]}